These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28757061)

  • 1. Radiosynthesis and evaluation of new PET ligands for peripheral cannabinoid receptor type 1 imaging.
    Yamasaki T; Fujinaga M; Shimoda Y; Mori W; Zhang Y; Wakizaka H; Ogawa M; Zhang MR
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4114-4117. PubMed ID: 28757061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
    Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
    Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: structure-activity relationship studies on 1-(4-chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1).
    German N; Decker AM; Gilmour BP; Gay EA; Wiley JL; Thomas BF; Zhang Y
    J Med Chem; 2014 Sep; 57(18):7758-69. PubMed ID: 25162172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.
    Bertini S; Chicca A; Gado F; Arena C; Nieri D; Digiacomo M; Saccomanni G; Zhao P; Abood ME; Macchia M; Gertsch J; Manera C
    Bioorg Med Chem; 2017 Dec; 25(24):6427-6434. PubMed ID: 29079014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum.
    Wang X; Horswill JG; Whalley BJ; Stephens GJ
    Mol Pharmacol; 2011 Apr; 79(4):758-67. PubMed ID: 21189269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor.
    Meini S; Gado F; Stevenson LA; Digiacomo M; Saba A; Codini S; Macchia M; Pertwee RG; Bertini S; Manera C
    Eur J Med Chem; 2020 Oct; 203():112606. PubMed ID: 32682199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB
    Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL
    Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
    Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
    Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cannabinoid Receptor-1 Is an Imaging Biomarker of Brown Adipose Tissue.
    Eriksson O; Mikkola K; Espes D; Tuominen L; Virtanen K; Forsbäck S; Haaparanta-Solin M; Hietala J; Solin O; Nuutila P
    J Nucl Med; 2015 Dec; 56(12):1937-41. PubMed ID: 26359260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.
    Nguyen T; German N; Decker AM; Langston TL; Gamage TF; Farquhar CE; Li JX; Wiley JL; Thomas BF; Zhang Y
    J Med Chem; 2017 Sep; 60(17):7410-7424. PubMed ID: 28792219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.
    Nguyen T; Gamage TF; Decker AM; Finlay DB; Langston TL; Barrus D; Glass M; Harris DL; Zhang Y
    Bioorg Med Chem; 2021 Jul; 41():116215. PubMed ID: 34015703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diarylureas Containing 5-Membered Heterocycles as CB
    Nguyen T; Gamage TF; Decker AM; German N; Langston TL; Farquhar CE; Kenakin TP; Wiley JL; Thomas BF; Zhang Y
    ACS Chem Neurosci; 2019 Jan; 10(1):518-527. PubMed ID: 30188693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
    Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
    Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new high-yield synthetic route to PET CB1 radioligands [11C]OMAR and its analogs.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3704-9. PubMed ID: 22542014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro biological evaluation of carbon-11-labeled quinoline derivatives as new candidate PET radioligands for cannabinoid CB2 receptor imaging.
    Gao M; Wang M; Miller KD; Hutchins GD; Zheng QH
    Bioorg Med Chem; 2010 Mar; 18(6):2099-2106. PubMed ID: 20189815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.
    Nguyen T; Gamage TF; Decker AM; Barrus D; Langston TL; Li JX; Thomas BF; Zhang Y
    J Med Chem; 2019 Nov; 62(21):9806-9823. PubMed ID: 31596583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.
    Fan H; Kotsikorou E; Hoffman AF; Ravert HT; Holt D; Hurst DP; Lupica CR; Reggio PH; Dannals RF; Horti AG
    Eur J Med Chem; 2009 Feb; 44(2):593-608. PubMed ID: 18511157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds.
    Röver S; Andjelkovic M; Bénardeau A; Chaput E; Guba W; Hebeisen P; Mohr S; Nettekoven M; Obst U; Richter WF; Ullmer C; Waldmeier P; Wright MB
    J Med Chem; 2013 Dec; 56(24):9874-96. PubMed ID: 24175572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a high affinity and selective pyridine analog as a potential positron emission tomography imaging agent for cannabinoid type 2 receptor.
    Slavik R; Grether U; Müller Herde A; Gobbi L; Fingerle J; Ullmer C; Krämer SD; Schibli R; Mu L; Ametamey SM
    J Med Chem; 2015 May; 58(10):4266-77. PubMed ID: 25950914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.